The IMMPACT factor or IMMPACT strikes again!
- PMID: 23911698
- DOI: 10.1016/j.pain.2013.07.051
The IMMPACT factor or IMMPACT strikes again!
Comment on
-
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.Pain. 2013 Nov;154(11):2324-2334. doi: 10.1016/j.pain.2013.06.035. Pain. 2013. PMID: 24148704 Review.
References
-
- Adams EH, Breiner S, Cicero TJ, Geller A, Inciardi JA, Schnoll SH, Senay EC, Woody GE. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage. 2006;31:465-476.
-
- Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von KM. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152:85-92.
-
- Edlund MJ, Martin BC, Fan MY, DeVries A, Braden JB, Sullivan MD. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend. 2010;112:90-98.
-
- Miehna E, Ross EL, Hynes WL, Nedeijkovic SS, Soumekh S, Janfaza D, Palombi D, Jamieson RN. Predicting aberrant drug behavior in patients treated for chronic pain. J Pain Symptom Manage. 2004;28:250-258.
-
- O’Connor AB, Turk DC, Dworkin RH, Katz NP, Colucci R, Haythornthwaite JA, Klein M, O’Brien C, Posner K, Rappaport RA, Reisfield G, Adams EH, Balster RL, Bigelow GE, Burke LB, Comer SD, Cone E, Cowan P, Denisco RA, Farrar JT, Foltin RW, Haddox JD, Hertz S, Jay GW, Junor R, Kopecky EA, Leiderman DB, McDermott MP, Palmer PP, Raja SN, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Smith SM, Sokolowska M, Stauffer JW, Walsh SL, Zacny JP. Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. PAIN®. 2013;154:2324-2334.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
